Generate Biomedicines Ownership | Who Owns Generate Biomedicines?
Generate Biomedicines Ownership Summary
Generate Biomedicines is owned by 8.22% institutional investors, 23.14% insiders, and 68.64% retail investors. Flagship pioneering is the largest institutional shareholder, holding 48.89% of GENB shares. American Funds SMALLCAP World A is the top mutual fund, with 2.93% of its assets in Generate Biomedicines shares.
GENB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Generate Biomedicines | 8.22% | 23.14% | 68.64% |
| Sector | Financial Services Stocks | 746.79% | 13.83% | -660.62% |
| Sector | Healthcare Stocks | 35.56% | 12.08% | 52.36% |
| Industry | Biotech Stocks | 35.43% | 12.01% | 52.56% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Flagship pioneering | 62.67M | 48.89% | $783.41M |
| Fmr | 4.22M | 3.29% | $52.72M |
| Capital world investors | 4.00M | 3.12% | $50.05M |
| Braidwell lp | 3.59M | 2.80% | $44.91M |
| Jpmorgan chase | 2.95M | 2.30% | $33.92M |
| Price t rowe associates inc /md/ | 2.11M | 1.65% | $26.37M |
| Arch venture management | 1.94M | 1.52% | $24.31M |
| Harbourvest partners | 1.72M | 1.34% | $21.53M |
| Baker bros. advisors lp | 1.42M | 1.11% | $17.80M |
| Harvard management | 1.11M | 0.87% | $13.89M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Flagship pioneering | 62.67M | 67.44% | $783.41M |
| Harbourvest partners | 1.72M | 21.33% | $21.53M |
| Arch venture management | 1.94M | 3.59% | $24.31M |
| Davern capital partners, lp | 591.80K | 2.03% | $7.40M |
| Braidwell lp | 3.59M | 1.50% | $44.91M |
| Harvard management | 1.11M | 0.76% | $13.89M |
| Sphera funds management | 185.00K | 0.37% | $2.31M |
| Siren | 736.10K | 0.26% | $9.20M |
| Affinity asset advisors | 350.00K | 0.23% | $4.38M |
| Centerbook partners lp | 266.81K | 0.18% | $3.34M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Flagship pioneering | 62.67M | 67.44% | 62.67M |
| Fmr | 4.22M | 0.00% | 4.22M |
| Capital world investors | 4.00M | 0.01% | 4.00M |
| Braidwell lp | 3.59M | 1.50% | 3.59M |
| Jpmorgan chase | 2.95M | 0.00% | 2.95M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Alyeska investment group | - | - | -500.00K |
| Exoduspoint capital management, lp | - | - | -311.99K |
| Jane street group | - | - | -123.37K |
| Silverarc capital management | - | - | -100.00K |
| D. e. shaw | - | - | -95.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Flagship pioneering | 62.67M | 67.44% | 62.67M | $783.41M |
| Fmr | 4.22M | 0.00% | 4.22M | $52.72M |
| Capital world investors | 4.00M | 0.01% | 4.00M | $50.05M |
| Braidwell lp | 3.59M | 1.50% | 3.59M | $44.91M |
| Jpmorgan chase | 2.95M | 0.00% | 2.95M | $33.92M |
Sold Out
| Holder | Change |
|---|---|
| Fny investment advisers | -3.00K |
| Diametric capital, lp | -10.50K |
| Hudson bay capital management lp | -16.68K |
| Y-intercept (hong kong) | -18.36K |
| Tudor investment corp et al | -23.83K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 28 | - | 10,533,115 | - | 8 | - | 28 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 3.75M | 2.93% | 102.60K |
| T. Rowe Price Health Sciences | 1.79M | 1.39% | - |
| Fidelity Growth Company Fund | 1.78M | 1.38% | 1.14M |
| ARK Genomic Revolution ETF | 1.26M | 0.98% | 27.59K |
| Fidelity Growth Compy Commingled Pl S | 989.76K | 0.77% | 141.50K |
| ARK Genomic Revolution | 833.27K | 0.65% | 358.32K |
| Vanguard Total Stock Mkt Idx Inv | 816.88K | 0.64% | 720.00K |
| Vanguard Morn Total Stk Mkt Idx Investor | 816.88K | 0.64% | 720.00K |
| JPMorgan Small Cap Growth A | 580.25K | 0.45% | -16.22K |
| Fidelity Growth Company K6 | 521.99K | 0.41% | 344.75K |
GENB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools